Note 11 — Earnings per Share

The following table summarizes the computation of basic and diluted earnings per share:

​

​

The table above does not include the following potential anti-dilutive shares: (i) up to 215,625 shares of common stock upon exercise of the Company’s outstanding public warrants at an exercise price of $460.00 per share for cash, (ii) up to 12,657 shares of common stock issuable upon exercise of the Company’s outstanding private placement warrants at an exercise price of $460.00 per share, (iii) up to 8,507 shares of common stock upon exercise of the financing warrants at an exercise price of $460.00 per share for cash, (iv) up to 7,634 shares of common stock upon the exercise of Company’s options, (v) 25,580 RSU awards issued yet unvested under the 2023 Incentive Award Plan as of March 31, 2026, (vi) up to 4,682,273.85 shares of common stock issuable upon exercise of the Company’s outstanding 2025 Warrants at an exercise price of $5.98, and (vii) up to 44,800 performance stock units committed via employment agreements but unissued as of March 31, 2026.